Table of Contents

company-logo

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.

Ocuphire Pharma Dividend Announcement

• Ocuphire Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Ocuphire Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Ocuphire Pharma Dividend History

Ocuphire Pharma Dividend Yield

Ocuphire Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ocuphire Pharma stock? Use our calculator to estimate your expected dividend yield:

Ocuphire Pharma Financial Ratios

P/E ratio-2.14
PEG ratio-0.06
P/B ratio0.74
ROE-30.19%
Payout ratio0.00%
Current ratio10.68
Quick ratio10.68
Cash Ratio9.86

Ocuphire Pharma Dividend FAQ

Does Ocuphire Pharma stock pay dividends?
Ocuphire Pharma does not currently pay dividends to its shareholders.
Has Ocuphire Pharma ever paid a dividend?
No, Ocuphire Pharma has no a history of paying dividends to its shareholders. Ocuphire Pharma is not known for its dividend payments.
Why doesn't Ocuphire Pharma pay dividends?
There are several potential reasons why Ocuphire Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ocuphire Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ocuphire Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ocuphire Pharma a dividend aristocrat?
Ocuphire Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ocuphire Pharma a dividend king?
Ocuphire Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ocuphire Pharma a dividend stock?
No, Ocuphire Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ocuphire Pharma stocks?
To buy Ocuphire Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ocuphire Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.